Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles

References

• 2006. Myozyme [package insert]. Genzyme Corporation.
   Google Scholar
• Aledort L, Ljung R, Mann K, Pipe S. 2014. Factor VIII therapy for hemophilia A: current and future issues. Expert Rev Hematol. 73:373–85.
   Google Scholar
• Arroyo A, Modriansky M, Serinkan FB, Bello RI, Matsura T, Jiang J, Tyurin VA, Tyurina YY, Fadeel B, Kagan VE. 2002. NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance. J Biol Chem. 27751:49965–75.
   Google Scholar
• Astermark J. 2011. Immune tolerance induction in patients with hemophilia A. Thromb Res. 127(Suppl 1):S6–9.
   PubMedGoogle Scholar
• Baker MP, Reynolds HM, Lumicisi B, Bryson CJ. 2010. Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self Nonself. 14:314–22.
   Google Scholar
• Bellini F, Bruni A. 1993. Role of a serum phospholipase A1 in the phosphatidylserine-induced T cell inhibition. FEBS Lett. 3161:1–4.
   Google Scholar
• Belzile O, Huang X, Gong J, Carlson J, Schroit AJ, Brekken RA, Freimark BD. 2018. Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer. Immunotargets Ther. 7:7–14.
   Web of Science ®Google Scholar
• Bevers EM, Williamson PL. 2016. Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane. Physiol Rev. 962:605–45.
   Google Scholar
• Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, Barcinski M, Brekken RA, Huang X, Hutchins JT, et al. 2016. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 23:962–78.
   PubMed Web of Science ®Google Scholar
• Borisenko GG, Iverson SL, Ahlberg S, Kagan VE, Fadeel B. 2004. Milk fat globule epidermal growth factor 8 (MFG-E8) binds to oxidized phosphatidylserine: implications for macrophage clearance of apoptotic cells. Cell Death Differ. 118:943–45.
   Google Scholar
• Chalasani P, Marron M, Roe D, Clarke K, Iannone M, Livingston RB, Shan JS, Stopeck AT. 2015. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer. Cancer Med. 47:1051–59.
   Google Scholar
• Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, Friedman P, Dennis EA, Witztum JL. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A. 9611:6353–58.
   Google Scholar
• Chaurio RA, Janko C, Munoz LE, Frey B, Herrmann M, Gaipl US. 2009. Phospholipids: key players in apoptosis and immune regulation. Molecules. 1412:4892–914.
   Google Scholar
• Chirino AJ, Ary ML, Marshall SA. 2004. Minimizing the immunogenicity of protein therapeutics. Drug Discov Today. 92:82–90.
   Google Scholar
• Chung IY, Jeong KH, Mi HS. 2017. Identification of lysophosphatidylserine receptor P2Y10 as a novel G-protein coupled receptor mediating eosinophil degranulation. J Immunol. 198(1 Supplement):201.14-.14.
   Web of Science ®Google Scholar
• Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 1961:135–40.
   Google Scholar
• de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA. 2001. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr Biol. 1123:1870–73.
   Google Scholar
• De Groot AS, Scott DW. 2007. Immunogenicity of protein therapeutics. Trends Immunol. 2811:482–90.
   Google Scholar
• Doerfler PA, Nayak S, Corti M, Morel L, Herzog RW, Byrne BJ. 2016. Targeted approaches to induce immune tolerance for Pompe disease therapy. Mol Ther Methods Clin Dev. 3:15053.
   PubMed Web of Science ®Google Scholar
• Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. 1998a. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 57:551–62.
   Google Scholar
• Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998b. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1014:890–98.
   Google Scholar
• Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. 1992a. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol. 14912:4029–35.
   Google Scholar
• Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992b. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1487:2207–16.
   Google Scholar
• Frasch SC, Berry KZ, Fernandez-Boyanapalli R, Jin HS, Leslie C, Henson PM, Murphy RC, Bratton DL. 2008. NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A. J Biol Chem. 28348:33736–49.
   Google Scholar
• Frasch SC, Bratton DL. 2012. Emerging roles for lysophosphatidylserine in resolution of inflammation. Prog Lipid Res. 513:199–207.
   Google Scholar
• Frasch SC, Fernandez-Boyanapalli RF, Berry KA, Murphy RC, Leslie CC, Nick JA, Henson PM, Bratton DL. 2013. Neutrophils regulate tissue neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine. J Biol Chem. 2887:4583–93.
   Google Scholar
• Frasch SC, Fernandez-Boyanapalli RF, Berry KZ, Leslie CC, Bonventre JV, Murphy RC, Henson PM, Bratton DL. 2011. Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity. J Biol Chem. 28614:12108–22.
   Google Scholar
• Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. 2010. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev. 2351:172–89.
   Google Scholar
• Fuller AD, Van Eldik LJ. 2008. MFG-E8 regulates microglial phagocytosis of apoptotic neurons. J Neuroimmune Pharmacol. 34:246–56.
   Google Scholar
• Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, Kalden JR, Herrmann M. 2006. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun. 9:173–87.
   PubMedGoogle Scholar
• Gaitonde P, Peng A, Straubinger RM, Bankert RB, Balu-Iyer SV. 2011. Phosphatidylserine reduces immune response against human recombinant Factor VIII in hemophilia A mice by regulation of dendritic cell function. Clin Immunol. 1382:135–45.
   Google Scholar
• Gaitonde P, Ramakrishnan R, Chin J, Kelleher RJ, Bankert RB, Balu-Iyer SV. 2013. Exposure to Factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward Factor VIII challenge in hemophilia A mice. J Bio Chem. 28824:17051–56.
   Google Scholar
• Gerber DE, Spigel DR, Giorgadze D, Shtivelband M, Ponomarova OV, Shan JS, Menander KB, Belani CP. 2016. Docetaxel combined with bavituximab in previously treated, advanced nonsquamous non-small-cell lung cancer. Clin Lung Cancer. 173:169–76.
   Google Scholar
• Glassman FY, Balu-Iyer SV. 2018. Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a hemophilia A mouse model. Int J Pharm. 5481:642–48.
   Google Scholar
• Glassman FY, Schneider JL, Ramakrishnan R, Dingman RK, Ramanathan M, Bankert RB, Balu-Iyer SV. 2018. Phosphatidylserine is not just a cleanup crew but also a well-meaning teacher. J Pharm Sci. doi:10.1016/j.xphs.2018.03.027
   PubMed Web of Science ®Google Scholar
• Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. 2006. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med. 20312:2613–25.
   Google Scholar
• Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R, Barbour SE, Milstien S, Spiegel S. 2008. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. FASEB J. 228:2629–38.
   Google Scholar
• Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 3045674:1147–50.
   Google Scholar
• Hankins HM, Baldridge RD, Xu P, Graham TR. 2015. Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution. Traffic. 161:35–47.
   Google Scholar
• Hoffmann PR, deCathelineau AM, Ogden CA, Leverrier Y, Bratton DL, Daleke DL, Ridley AJ, Fadok VA, Henson PM. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol. 1554:649–59.
   Google Scholar
• Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2995609:1057–61.
   Google Scholar
• Julian L, Olson MF. 2015. Apoptotic membrane dynamics in health and disease. Cell Health Cytoskelet. 7:133–42.
   Web of Science ®Google Scholar
• Kagan VE, Gleiss B, Tyurina YY, Tyurin VA, Elenstrom-Magnusson C, Liu SX, Serinkan FB, Arroyo A, Chandra J, Orrenius S, et al. 2002. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J Immunol. 1691:487–99.
   Google Scholar
• Kay JG, Grinstein S. 2013. Phosphatidylserine-mediated cellular signaling. Adv Exp Med Biol. 991:177–93.
   PubMed Web of Science ®Google Scholar
• Kelleher RJ Jr., Balu-Iyer S, Loyall J, Sacca AJ, Shenoy GN, Peng P, Iyer V, Fathallah AM, Berenson CS, Wallace PK, et al. 2015. Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade. Cancer Immunol Res. 311:1269–78.
   Google Scholar
• Kerr D, Tietjen GT, Gong Z, Tajkhorshid E, Adams EJ, Lee KYC. 2018. Sensitivity of peripheral membrane proteins to the membrane context: a case study of phosphatidylserine and the TIM proteins. Biochimica et Biophysica Acta (BBA) - Biomembranes. 186010:2126–33.
   Google Scholar
• Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y, Birge RB. 2014. Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity. Front Immunol. 5:566.
   PubMed Web of Science ®Google Scholar
• Kitamura H, Makide K, Shuto A, Ikubo M, Inoue A, Suzuki K, Sato Y, Nakamura S, Otani Y, Ohwada T, et al. 2012. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position. J Biochem. 1515:511–18.
   Google Scholar
• Klinge J, Ananyeva NM, Hauser CA, Saenko EL. 2002. Hemophilia A–from basic science to clinical practice. Semin Thromb Hemost. 283:309–22.
   Google Scholar
• Kobayashi N, Karisola P, Peña-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, Butte MJ, Nagumo H, Chernova I, Zhu B. 2007. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 276:927–40.
   Google Scholar
• Lankry D, Rovis TL, Jonjic S, Mandelboim O. 2013. The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells. Eur J Immunol. 438:2151–61.
   Google Scholar
• Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 1136:717–30.
   Google Scholar
• Leventis PA, Grinstein S. 2010. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 39:407–27.
   PubMed Web of Science ®Google Scholar
• Lollar P, Healey JF, Barrow RT, Parker ET. 2001. Factor VIII inhibitors. Adv Exp Med Biol. 489:65–73.
   PubMed Web of Science ®Google Scholar
• Lu Q, Lemke G. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2935528:306–11.
   Google Scholar
• Mahajan A, Herrmann M, Munoz LE. 2016. Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE. Front Immunol. 7:35.
   PubMed Web of Science ®Google Scholar
• Makide K, Aoki J. 2013. GPR34 as a lysophosphatidylserine receptor. J Biochem. 1534:327–29.
   Google Scholar
• Marino G, Kroemer G. 2013. Mechanisms of apoptotic phosphatidylserine exposure. Cell Res. 2311:1247–48.
   Google Scholar
• Matsura T, Serinkan BF, Jiang J, Kagan VE. 2002. Phosphatidylserine peroxidation/externalization during staurosporine-induced apoptosis in HL-60 cells. FEBS Lett. 5241–3:25–30.
   Google Scholar
• Meyer J, Arriaga Y, Anandam J, Karri S, Syed S, Verma U, Abdelnaby A, Raja G, Dong Y, Beg M, et al. 2017. A Phase I clinical trial of the phosphatidylserine-targeting antibody bavituximab in combination with radiation therapy and capecitabine in the preoperative treatment of rectal adenocarcinoma. Am J Clin Oncol. 41:972–76.
   Web of Science ®Google Scholar
• Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature. 4507168:435–39.
   Google Scholar
• Mueller RB, Sheriff A, Gaipl US, Wesselborg S, Lauber K. 2007. Attraction of phagocytes by apoptotic cells is mediated by lysophosphatidylcholine. Autoimmunity. 404:342–44.
   Google Scholar
• Munoz LE, Franz S, Pausch F, Furnrohr B, Sheriff A, Vogt B, Kern PM, Baum W, Stach C, von Laer D, et al. 2007a. The influence on the immunomodulatory effects of dying and dead cells of Annexin V. J Leukoc Biol. 811:6–14.
   Google Scholar
• Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B, Poschl E, Rodel F, von der Mark K, Herrmann M, et al. 2007b. The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr Med Chem. 143:271–77.
   Google Scholar
• Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. 2010. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 65:280–89.
   Google Scholar
• Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW, Ravichandran KS. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature. 4507168:430–34.
   Google Scholar
• Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, Lee BH, Kwon TH, Park RW, Kim IS. 2008a. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 151:192–201.
   Google Scholar
• Park SY, Kim SY, Jung MY, Bae DJ, Kim IS. 2008b. Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol Cell Biol. 2817:5288–98.
   Google Scholar
• Pujol-Autonell I, Mansilla MJ, Rodriguez-Fernandez S, Cano-Sarabia M, Navarro-Barriuso J, Ampudia RM, Rius A, Garcia-Jimeno S, Perna-Barrull D, Martinez-Caceres E, et al. 2017. Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis. Nanomedicine (Lond). 1211:1231–42.
   Google Scholar
• Pujol-Autonell I, Serracant-Prat A, Cano-Sarabia M, Ampudia RM, Rodriguez-Fernandez S, Sanchez A, Izquierdo C, Stratmann T, Puig-Domingo M, Maspoch D, et al. 2015. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes. PLoS One. 106:e0127057.
   Google Scholar
• Purohit VS, Ramani K, Sarkar R, Kazazian HH Jr., Balasubramanian SV. 2005. Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex. J Biol Chem. 28018:17593–600.
   Google Scholar
• Raben N, Plotz P, Byrne BJ. 2002. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med. 22:145–66.
   Google Scholar
• Ramakrishnan R, Davidowitz A, Balu-Iyer SV. 2015. Exposure of FVIII in the presence of phosphatidyl serine reduces generation of memory B-cells and induces regulatory T-cell-mediated hyporesponsiveness in hemophilia a mice. J Pharm Sci. 1048:2451–56.
   Google Scholar
• Ramani K, Miclea RD, Purohit VS, Mager DE, Straubinger RM, Balu-Iyer SV. 2008. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. J Pharm Sci. 974:1386–98.
   Google Scholar
• Ravichandran KS. 2010. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med. 2079:1807–17.
   Google Scholar
• Ring GH, Lakkis FG. 1999. Breakdown of self-tolerance and the pathogenesis of autoimmunity. Semin Nephrol. 191:25–33.
   Google Scholar
• Rodriguez-Fernandez S, Pujol-Autonell I, Brianso F, Perna-Barrull D, Cano-Sarabia M, Garcia-Jimeno S, Villalba A, Sanchez A, Aguilera E, Vazquez F, et al. 2018. Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human Type 1 diabetes by apoptotic mimicry. Front Immunol. 9:253.
   PubMed Web of Science ®Google Scholar
• Schneider JL, Balu-Iyer SV. 2016. Phosphatidylserine converts immunogenic recombinant human acid alpha-glucosidase to a tolerogenic form in a mouse model of pompe disease. J Pharm Sci. 10510:3097–104.
   Google Scholar
• Segawa K, Nagata S. 2015. An apoptotic ‘eat me’ signal: phosphatidylserine exposure. Trends Cell Biol. 2511:639–50.
   Google Scholar
• Segawa K, Suzuki J, Nagata S. 2011. Constitutive exposure of phosphatidylserine on viable cells. Proc Natl Acad Sci U S A. 10848:19246–51.
   Google Scholar
• Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK. 2007. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol. 1789:5635–42.
   Google Scholar
• Shao WH, Cohen PL. 2011. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther. 131:202.
   Google Scholar
• Simon HU, Haj-Yehia A, Levi-Schaffer F. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 55:415–18.
   Google Scholar
• Soares MM, King SW, Thorpe PE. 2008. Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat Med. 1412:1357–62.
   Google Scholar
• Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, Sato S, Kikuchi K, Nagi T, Harada M, Ogi K, et al. 2006. Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun. 3414:1078–87.
   Google Scholar
• Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. 2013. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science. 3416144:403–06.
   Google Scholar
• Suzuki J, Imanishi E, Nagata S. 2014. Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. J Biol Chem. 28944:30257–67.
   Google Scholar
• Suzuki J, Umeda M, Sims PJ, Nagata S. 2010. Calcium-dependent phospholipid scrambling by TMEM16F. Nature. 4687325:834–38.
   Google Scholar
• Tietjen GT, Gong Z, Chen CH, Vargas E, Crooks JE, Cao KD, Heffern CT, Henderson JM, Meron M, Lin B, et al. 2014. Molecular mechanism for differential recognition of membrane phosphatidylserine by the immune regulatory receptor Tim4. Proc Natl Acad Sci U S A. 11115:E1463–72.
   Google Scholar
• Tyurin VA, Balasubramanian K, Winnica D, Tyurina YY, Vikulina AS, He RR, Kapralov AA, Macphee CH, Kagan VE. 2014. Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic ‘eat-me’ signals: cleavage and inhibition of phagocytosis by Lp-PLA2. Cell Death Differ. 215:825–35.
   Google Scholar
• van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, Espevik T, de Jong EC, Kapsenberg ML, Golenbock DT, et al. 2002. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem. 27750:48122–29.
   Google Scholar
• van der Kleij D, Yazdanbakhsh M. 2003. Control of inflammatory diseases by pathogens: lipids and the immune system. Eur J Immunol. 3311:2953–63.
   Google Scholar
• Verhoven B, Schlegel R, Williamson P. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med. 1825:1597–601.
   Google Scholar
• Xiao S, Brooks CR, Zhu C, Wu C, Sweere JM, Petecka S, Yeste A, Quintana FJ, Ichimura T, Sobel RA, et al. 2012. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci U S A. 10930:12105–10.
   Google Scholar
• Yin Y, Huang X, Lynn KD, Thorpe PE. 2013. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res. 14:256–68.
   Google Scholar